Respiratory specialists Dr Anna Haley and Dr Nita Sehgal discuss the key principles in management of asthma during pregnancy ...
Objectives Despite reducing exposures to wood dust, woodworkers remain at increased risk of asthma. There have been no recent studies of wood dust exposure, respiratory symptoms or asthma in British ...
The U.S. Food and Drug Administration has approved Exdensur (depemokimab-ulaa) as an add-on maintenance treatment for severe asthma with an eosinophilic phenotype in adult and pediatric patients aged ...
Moving cannabis to a category of drugs that includes some common medicines will have implications for research, businesses and patients. By Jan Hoffman President Trump on Thursday ordered cannabis to ...
The FDA approved depemokimab (Exdensur) as the first ultra-long-acting biologic with twice-yearly dosing approved for patients with severe asthma with an eosinophilic phenotype, GSK announced. The ...
A new option for hard-to-control asthma: The FDA has approved Exdensur (depemokimab-ulaa) as an add-on maintenance treatment for people with severe asthma. Designed to reduce flare-ups: The injectable ...
People with severe asthma sometimes rely on daily steroid pills, which raise the risk of diabetes, infections and bone problems. Now, a study supports the idea that a monthly antibody injection is a ...
A groundbreaking international study has shown that a 2-in-1 budesonide-formoterol inhaler is far more effective than the standard salbutamol inhaler in children with mild asthma, cutting attacks by ...
Inhalers that combine providing immediate relief with a longer-term preventative effect are already recommended as the standard treatment for mild asthma among people aged 12 and above in the UK, US ...
SYRACUSE, N.Y. — As the third week of September unfolds, doctors are alerting asthma sufferers to brace for what is known as "Asthma Peak Week," a period marked by worsening symptoms and increased ...
Three years on from a splashy unveiling, Areteia Therapeutics has reported a phase 3 victory that could boost its bid to launch an oral rival to the biologics that dominate a multibillion-dollar ...
The Lehigh Valley once again has been named among the most challenging areas in the United States for people living with asthma, according to a new report released by the Asthma and Allergy Foundation ...